Back to resultsActivity Monitoring Assessment of Opiate Withdrawal - 4
Primary Purpose
Opioid-Related Disorders
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Morphine
Sponsored by
About this trial
This is an interventional treatment trial for Opioid-Related Disorders focused on measuring opioid dependence
Eligibility Criteria
Please contact site for information.
Sites / Locations
- Washington DC VA
Outcomes
Primary Outcome Measures
Depression
Anxiety
Withdrawal severity
Activity
Opiate secondary withdrawal
Secondary Outcome Measures
Full Information
NCT ID
NCT00000335
First Posted
September 20, 1999
Last Updated
January 30, 2017
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
Washington D.C. Veterans Affairs Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT00000335
Brief Title
Activity Monitoring Assessment of Opiate Withdrawal - 4
Official Title
Activity Monitoring Assessment of Opiate Withdrawal
Study Type
Interventional
2. Study Status
Record Verification Date
December 2002
Overall Recruitment Status
Completed
Study Start Date
September 30, 1995 (Actual)
Primary Completion Date
March 20, 1996 (Actual)
Study Completion Date
May 20, 1996 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
Washington D.C. Veterans Affairs Medical Center
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to determine if hyperactivity accompanies abrupt opiate withdrawal in heroin addicts, to determine if computerized solid state activity monitors are capable of quantifying hyperactivity, and to quantify the physical and affective symptoms occurring during abrupt withdrawal in heroin addicts and morphine's capacity to alleviate these symptoms.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Opioid-Related Disorders
Keywords
opioid dependence
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Enrollment
0 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Morphine
Primary Outcome Measure Information:
Title
Depression
Title
Anxiety
Title
Withdrawal severity
Title
Activity
Title
Opiate secondary withdrawal
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steven Deutsch, M.D.
Organizational Affiliation
Washington D.C. Veterans Affairs Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Washington DC VA
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20422
Country
United States
12. IPD Sharing Statement
Citations:
Citation
1996 CPDD, NIDA Research Monograph
Results Reference
background
Learn more about this trial
Activity Monitoring Assessment of Opiate Withdrawal - 4
We'll reach out to this number within 24 hrs